Physician profile
Saeed U Khaja
NPI 1316289606
$54,575.12
in general payments reported to CMS, 2019-2025
31 companies · $6,634 in 2025
The $6,634 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $18K · 2021: $2,331 · 2022: $1,324 · 2023: $1,785 · 2024: $8,090 · 2025: $6,634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,975 · Food and Beverage: $6,228 · Travel and Lodging: $3,306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,975.00 |
| Food and Beverage | $6,228.31 |
| Travel and Lodging | $3,306.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $17,119.05 | 2019-2020 | |
| Boston Scientific Corporation | $12,321.70 | 2019-2025 | Watchman Flx, Farapulse, Watchman |
| Biosense Webster, INC. | $7,371.24 | 2021-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Medtronic, INC. | $7,293.59 | 2021-2025 | Evera Mri Xt Dr Surescan, Cobalt Dr Mri Surescan, Micra |
| Abbott Laboratories | $4,616.17 | 2019-2023 | Ensite |
| Biotronik INC. | $2,466.17 | 2019 | |
| Merck Sharp & Dohme LLC | $464.51 | 2021-2025 | Verquvo |
| Abiomed | $411.66 | 2022-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $389.48 | 2019-2025 | Farxiga, Breztri, Andexxa |
| E.R. Squibb & Sons, L.L.C. | $302.23 | 2021-2025 | Eliquis, Camzyos |
| Medical Device Business Services, INC. | $252.20 | 2024 | Carto 3 |
| Novartis Pharmaceuticals Corporation | $228.20 | 2021-2024 | |
| Elutia, INC. | $213.93 | 2023 | |
| Amgen INC. | $208.65 | 2021-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $159.64 | 2019-2025 | Lifevest |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $137.92 | 2023 | |
| Sanofi-Aventis U.S. LLC | $133.82 | 2021-2022 | |
| Pfizer INC. | $122.38 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.89 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $54.38 | 2022 | |
| Kestra Medical Technology Services, INC. | $50.80 | 2025 | Assure Wcd |
| Terumo Medical Corporation | $36.09 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.66 | 2019-2025 | Jardiance |
| Zoll Circulation INC | $28.09 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $20.26 | 2024 | Arcalyst |
| Inspire Medical Systems, INC. | $17.49 | 2025 | Inspire |
| Novo Nordisk INC | $15.37 | 2025 | Wegovy |
| Glaxosmithkline, LLC. | $15.30 | 2025 | Shingrix, Arexvy |
| Bardy Diagnostics, INC. | $12.00 | 2022 | |
| Altathera Pharmaceuticals LLC | $11.14 | 2025 | Sotalol Hydrochloride |
| Cvrx, INC. | $6.11 | 2023 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saeed Khaja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.